High severity · published Mar 23, 2019
CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call…
8.8
CVSS
2.9%
EPSS
No
On KEV
Description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
CVSS vector
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack vector
Network
Complexity
Low
Privileges
Low
User interaction
None
Confidentiality
High
Integrity
High
Availability
High
Scope
Unchanged
Exploitation
Is it being used?
Exploit prediction (EPSS)2.9% · higher than 87% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
SI
Symbiq Infusion System Firmware · Pfizer
through 3.13 · source: NVD